Introduction: Extracorporeal membrane oxygenation (ECMO) is becoming an important therapeutic option for patients with severe acute respiratory distress syndrome (ARDS). Pneumothorax is a known complication of mechanical ventilator strategy in ARDS. Anticoagulation given during ECMO increases the chance of uncontrolled bleeding. We report management of hemopneumothorax in a patient with kyphoscoliosis, hypothyroidism, and acute viral pneumonia in a patient with severe ARDS who was on ECMO support.
In developing countries, there are a growing number of patients with complex heart and lung disease (both adults and pediatric population) that is coupled with an environment of scarce resources. There is, therefore, a huge need for the adoption of modern medical technology in the field of mechanical circulatory systems, including extracorporeal membrane oxygenation (ECMO) treatments. The development of ECMO in particular has been extremely slow, and no system is currently approved and available for clinical application in developing countries, such as Pakistan. Reasons include financial constraints that have been a barrier to the development of robust adult and pediatric cardiac intensive care units critical to the success of such programs. Second, because of substantial resource limitations, the existing models of such care cannot be applied in their existing forms without addressing the numerous challenges that limit the delivery of ECMO in the developing world. Other limitations include absence of skilled technologists and material resources for adapting such technologies. Additionally, there is need to adopt strategies for delivering to the patients and health care providers such technologies at affordable costs. Here, we present a framework for the establishment of a new ECMO program in a resource-limited environment typically encountered in the developing world and the emerging economies. 
A8 Management of Hemopneumothorax on Venoarterial

